The new regimen is for adults with unresectable or metastatic HER2-positive breast cancer that did not worsen during initial ...
The FDA’s October 2026 approval of pirtobrutinib gives adults with previously untreated CLL/SLL (without del17p) another ...
If you’re eligible for a stem cell transplant, the data is clear: patients who get one live longer than those who don’t. However, not everyone is eligible for a stem cell transplant because of the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results